Schwerin Boyle Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
WA
Schwerin Boyle Capital Management's MDT Position: Q3 2021 in Review
Schwerin Boyle Capital Management sold out of Medtronic (MDT) in Q3 2021, closing a stake of 60,000 shares — an estimated $7.45M sold.
Schwerin Boyle Capital Management first reported a position in MDT in Q2 2013 and held it in 33 quarters. The position peaked at $7.45M in Q2 2021. 2,023 funds tracked by Wall St. Rank hold MDT as of Q3 2021.
- Schwerin Boyle Capital Management reported no remaining Medtronic position as of Q3 2021 after selling out during the quarter.
- Schwerin Boyle Capital Management sold 60,000 Medtronic shares in Q3 2021, an estimated $7.45M.
- Schwerin Boyle Capital Management first reported a position in Medtronic in Q2 2013 and held it in 33 quarters.
- Schwerin Boyle Capital Management's Medtronic position peaked at $7.45M in Q2 2021.
- 2,023 funds tracked by Wall St. Rank held Medtronic as of Q3 2021.
Based on Schwerin Boyle Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.